A bispecific antibody composed of a nonneutralizing antibody to the gp41 immunodominant region and an anti-CD89 antibody directs broad human immunodeficiency virus destruction by neutrophils

被引:27
作者
Duval, Mark [1 ,2 ]
Posner, Marshall R. [1 ,2 ]
Cavacini, Lisa A. [1 ,2 ]
机构
[1] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA 02215 USA
关键词
D O I
10.1128/JVI.02499-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In addition to the direct neutralization of virus, there is a broader potential for antibody-mediated inhibition of human immunodeficiency virus (HIV) by targeting HIV to effector cells. We demonstrate here that a bispecific antibody incorporating a broadly reactive anti-gp41. antibody, F240, and an anti-IgA receptor (CD89) antibody is effective at directing neutrophils to destroy HIV. Not only are neutrophils the predominant type of white blood cells and very efficient at mediating cell cytotoxicity, they are relatively resistant to infection with HIV. Therefore, they represent a significant weapon against infection if they can be directed and armed to destroy HIV and infected cells.
引用
收藏
页码:4671 / 4674
页数:4
相关论文
共 37 条
  • [1] Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
    Baba, TW
    Liska, V
    Hofmann-Lehmann, R
    Vlasak, J
    Xu, WD
    Ayehunie, S
    Cavacini, LA
    Posner, MR
    Katinger, H
    Stiegler, G
    Bernacky, BJ
    Rizvi, TA
    Schmidt, R
    Hill, LR
    Keeling, ME
    Lu, YC
    Wright, JE
    Chou, TC
    Ruprecht, RM
    [J]. NATURE MEDICINE, 2000, 6 (02) : 200 - 206
  • [2] Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41
    Burrer, R
    Haessig-Einius, S
    Aubertin, AM
    Moog, C
    [J]. VIROLOGY, 2005, 333 (01) : 102 - 113
  • [3] ANTICANDIDAL ACTIVITY AND INTERLEUKIN-1-BETA AND INTERLEUKIN-6 PRODUCTION BY POLYMORPHONUCLEAR LEUKOCYTES ARE PRESERVED IN SUBJECTS WITH AIDS
    CASSONE, A
    PALMA, C
    DJEU, JY
    AIUTI, F
    QUINTI, I
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (05) : 1354 - 1357
  • [4] Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individuals
    Cavacini, LA
    Peterson, JE
    Nappi, E
    Duval, M
    Goldstein, R
    Mayer, K
    Posner, MR
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (11) : 9638 - 9641
  • [5] Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41
    Cavacini, LA
    Emes, CL
    Wisnewski, AV
    Power, J
    Lewis, G
    Montefiori, D
    Posner, MR
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (14) : 1271 - 1280
  • [6] Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses
    Chen, Ping
    Huebner, Wolfgang
    Spinelli, Matthew A.
    Chen, Benjamin K.
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (22) : 12582 - 12595
  • [7] Deo YM, 1998, J IMMUNOL, V160, P1677
  • [8] POLYMORPHONUCLEAR NEUTROPHILS FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS SHOW ENHANCED ACTIVATION, DIMINISHED FMLP-INDUCED L-SELECTIN SHEDDING, AND AN IMPAIRED OXIDATIVE BURST AFTER CYTOKINE PRIMING
    ELBIM, C
    PREVOT, MH
    BOUSCARAT, F
    FRANZINI, E
    CHOLLETMARTIN, S
    HAKIM, J
    GOUGEROTPOCIDALO, MA
    [J]. BLOOD, 1994, 84 (08) : 2759 - 2766
  • [9] Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies
    Ferrantelli, F
    Rasmussen, RA
    Buckley, KA
    Li, PL
    Wang, T
    Montefiori, DC
    Katinger, H
    Stiegler, G
    Anderson, DC
    McClure, HM
    Ruprecht, RM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (12) : 2167 - 2173
  • [10] Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques
    Ferrantelli, F
    Hofmann-Lehmann, R
    Rasmussen, RA
    Wang, T
    Xu, WD
    Li, PL
    Montefiori, DC
    Cavacini, LA
    Katinger, H
    Stiegler, G
    Anderson, DC
    McClure, HM
    Ruprecht, RM
    [J]. AIDS, 2003, 17 (03) : 301 - 309